Company Overview and News

 
JJSF / J & J Snack Foods Corp. FORM 8-K (Current Report)

2018-05-21 sec.gov
jjsf20180518_8k.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 <

 
JJSF / J & J Snack Foods Corp. FORM 10-Q (Quarterly Report)

2018-05-03 sec.gov
jjsf20180331_10q.htm UNITED STATES

 
J & J Snack Foods' (JJSF) CEO Gerald Shreiber on Q2 2018 Results - Earnings Call Transcript

2018-05-01 seekingalpha
Welcome to the J & J Snack Foods Second Quarter Earnings Conference Call. My name is John, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions]. Please note the conference is being recorded.

 
JJSF / J & J Snack Foods Corp. FORM 8-K (Current Report)

2018-04-30 sec.gov
jjsf20180427b_8k.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 <

 
JJSF / J & J Snack Foods Corp. FORM 8-K (Current Report)

2018-02-12 sec.gov
jjsf20180212_8k.htm   SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): February 9, 2018     J & J SNACK FOODS CORP.   (Exact name of registrant as specified in its charter)   New Jersey 0-14616 22-1935537 (State or Other (Commission (I.R.S. Employer Jurisdiction of Organization) File Number) Identification No.

 
JJSF / J & J Snack Foods Corp. FORM 8-K (Current Report)

2018-02-12 sec.gov
jjsf20180209_8k.htm   SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): February 12, 2018   J & J SNACK FOODS CORP.   (Exact name of registrant as specified in its charter)     New Jersey 0-14616 22-1935537         (State or Other (Commission  (I.

 
JJSF / J & J Snack Foods Corp. / BlackRock Inc. - 3G/A (Passive Investment)

2018-02-09 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 10) J & J SNACK FOODS CORP -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 466032109 -------------------------------------------------------- (CUSIP Number) January 31, 2018 -------------------------------------------------------- (Date of Event

 
JJSF / J & J Snack Foods Corp. / BlackRock Inc. - 3G/A (Passive Investment)

2018-02-09 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 10) J & J SNACK FOODS CORP -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 466032109 -------------------------------------------------------- (CUSIP Number) January 31, 2018 -------------------------------------------------------- (Date of Event

 
JJSF / J & J Snack Foods Corp. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
jjsnackfoodscorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 4 )*       Name of issuer:  J&J Snack Foods Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  466032109     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) R

 
JJSF / J & J Snack Foods Corp. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
jjsnackfoodscorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 4 )*       Name of issuer:  J&J Snack Foods Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  466032109     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) R

 
JJSF / J & J Snack Foods Corp. FORM 10-Q (Quarterly Report)

2018-02-02 sec.gov
jjsf20171229_10q.htm UNITED STATES

 
JJSF / J & J Snack Foods Corp. / SHREIBER GERALD B - SCHEDULE 13G/A (Passive Investment)

2018-01-31 sec.gov
shreiber20180130_sc13ga.htm     OMB Approval       UNITED STATES OMB Number: 3235-0145     SECURITIES AND EXCHANGE COMMISSION Expires: February 28, 2009     Washington, D.C. 20549 Estimated average burden hours per response 10.4   SCHEDULE 13G     Under the Securities Exchange Act of 1934 (Amendment No. 30)*     J & J Snack Foods Corp. (Name of Issuer)   Common Stock, No Par Value (Title of Class of Securities)     466032109     (CUSIP Number)       December 31, 2017     (Date of Event Which Req

 
JJSF / J & J Snack Foods Corp. / SHREIBER GERALD B - SCHEDULE 13G/A (Passive Investment)

2018-01-31 sec.gov
shreiber20180130_sc13ga.htm     OMB Approval       UNITED STATES OMB Number: 3235-0145     SECURITIES AND EXCHANGE COMMISSION Expires: February 28, 2009     Washington, D.C. 20549 Estimated average burden hours per response 10.4   SCHEDULE 13G     Under the Securities Exchange Act of 1934 (Amendment No. 30)*     J & J Snack Foods Corp. (Name of Issuer)   Common Stock, No Par Value (Title of Class of Securities)     466032109     (CUSIP Number)       December 31, 2017     (Date of Event Which Req

 
J&J Snack Foods' (JJSF) CEO Gerald Shreiber on Q1 2018 Results - Earnings Call Transcript

2018-01-30 seekingalpha
J&J Snack Foods Corp (NASDAQ:JJSF) Q1 2018 Earnings Conference Call January 30, 2018 10:00 AM ET

 
JJSF / J & J Snack Foods Corp. FORM 8-K (Current Report)

2018-01-29 sec.gov
jjsf20180129_8k.htm   SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): January 29, 2018   J & J SNACK FOODS CORP.   (Exact name of registrant as specified in its charter)   New Jersey 0-14616 22-1935537 (State or Other (Commission (I.R.S. Employer Jurisdiction of Organization)  File Number) Identification No.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 466032109